Ad is loading...
MENU
GRCE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Grace Therapeutics (GRCE) Ownership - Who owns Grace Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
34.88M
P/E Ratio
N/A
Total Cash
15.17M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.91
Dividend Yield
N/A
Total Cash/Share
1.50
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GRCE
Capitalization
34.9M
P/E Ratio
N/A
Risk (Beta)
0.91
Dividend Yield
N/A
Total Cash
15.2M
Total Cash/Share
1.50
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
56.1M
P/B Ratio
0.62
Cash Flow
N/A
Earnings
-1.29
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
261M
Current Ratio
6.01
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-16.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-16.17
Shares Held By Institutions
7.02M
Shares Outstanding - Current
10.1M
Total Liabilities
9.22M
Total Volume MTD
N/A
Value
N/A
Gain YTD
19.031
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of Pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A